PolyXen 平台 :PolyXen是蛋白质和肽药物输送的使能平台技术。它使用生物聚合物聚唾液酸(PSA)来延长药物的半衰期,并可能提高治疗肽和蛋白质的稳定性。附着部位和PSA链的长度都可以通过改变分子的表观流体力学半径来影...查看全文
牛股小红书2022-04-28 13:48
$Xenetic Biosciences(XBIO)$ 与CLS Therapeutics签署了独家许可和再许可协议,以开发其基于DNA酶的介入性肿瘤学平台,旨在改善现有治疗,包括免疫疗法。
根据协议,Xenetic拥有CLS知识产权的独家许可证,用于在癌症中使用DNA酶,包括DNA酶与标准疗法(包括化疗、放疗和检查点抑制剂)的系统联...查看全文
$Xenetic Biosciences(XBIO)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-07-02 AccNo: 0001683168-19-002077 Size: 5 MB 网页链接
$Xenetic Biosciences(XBIO)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-06-24 AccNo: 0001683168-19-001987 Size: 1 MB 网页链接
$Xenetic Biosciences(XBIO)$ 8-K - Current report Filed: 2019-06-24 AccNo: 0001683168-19-001995 Size: 98 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or ...
$Xenetic Biosciences(XBIO)$ 8-K - Current report Filed: 2019-06-25 AccNo: 0001683168-19-002001 Size: 207 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$Xenetic Biosciences(XBIO)$ 美东时间 2019-06-25 拆合股: 12合1 网页链接
$Xenetic Biosciences(XBIO)$ 425 - Prospectuses and communications, business combinations Filed: 2019-06-18 AccNo: 0001683168-19-001926 Size: 9 MB 网页链接
$Xenetic Biosciences(XBIO)$ 425 - Prospectuses and communications, business combinations Filed: 2019-06-13 AccNo: 0001683168-19-001892 Size: 57 KB 网页链接
$Xenetic Biosciences(XBIO)$ 8-K - Current report Filed: 2019-06-13 AccNo: 0001683168-19-001891 Size: 56 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Xenetic Biosciences(XBIO)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-05-24 AccNo: 0001683168-19-001725 Size: 1 MB 网页链接
$Xenetic Biosciences(XBIO)$ EFFECT - Notice of Effectiveness Filed: 2019-05-22 AccNo: 9999999995-19-001174 Size: 1 KB 网页链接